Cadrenal Therapeutics, Inc. Common Stock

CVKD

Cadrenal Therapeutics, Inc. (CVKD) is a clinical-stage biopharmaceutical company focused on developing innovative therapies for cardiovascular and related diseases. The company is dedicated to advancing treatments that address unmet medical needs, leveraging its expertise in novel drug discovery and development.

$10.28 +0.10 (0.98%)
🚫 Cadrenal Therapeutics, Inc. Common Stock does not pay dividends

Company News

Kuick Research Releases Landmark Study On US Orphan Drug Rare Disease Market Highlighting Investment And Innovation Opportunities Through 2030
Benzinga • Neeraj Chawla • October 31, 2025

Kuick Research released a comprehensive study on the US Orphan Drug Market, projecting market opportunities exceeding $190 billion by 2030, with over 850 orphan drugs in clinical trials and 500 marketed orphan drugs, highlighting significant investment potential in rare disease therapeutics.

MRKGILDABT
Presenting on the Emerging Growth Conference 73 Day 2 on July 18 Register Now - GlobeNewswire
GlobeNewswire Inc. • N/A • July 17, 2024

The 73rd Emerging Growth Conference is scheduled for July 17-18, 2024, featuring presentations from various companies in the healthcare, technology, and energy sectors.

IMRNGDTCATRAAYTUCLNNCLNNW
IPO Round Up of First Half of 2023
Zacks Investment Research • Sanghamitra Saha • July 5, 2023

Normally, IPO activity gains momentum in the second quarter and peaks in June. This year was no exception.

IPOLICNSKWDGNLXGPCRSFWL

Related Companies

CVR ENERGY, INC.
CVR ENERGY, INC.
CVI
Calvert International Responsible Index ETF
Calvert International Responsible Index ETF
CVIE
Covenant Logistics Group, Inc.
Covenant Logistics Group, Inc.
CVLG
Calvert US Large-Cap Core Responsible Index ETF
Calvert US Large-Cap Core Responsible Index ETF
CVLC